InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by LeBel Carl, Directeur du Développement. Insider active across 1 company, notably Frequency Therapeutics, Inc.. Aggregated, 4 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €10k. Activity tracked since 16 February 2022. The latest transaction was disclosed on 18 February 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
974 shares@ US$3.87333.9% of flowCommon StockSEC:0001127602-22-006321:0
831 shares@ US$4.42933.1% of flowCommon StockSEC:0001127602-22-005750:0
831 shares@ US$4.429100.0% of flowCommon StockSEC:0001127602-22-005750
15,000 sharesCommon StockSEC:0001127602-22-005336:0
4 of 4 declarations
About LeBel Carl
Carl LeBel serves as the Chief Development Officer at Frequency Therapeutics, Inc. He is responsible for leading the company's strategic development initiatives. With his expertise, he plays a key role in driving innovation and business growth.
